Predictive model for the risk of cytokine release syndrome with glofitamab treatment for diffuse large B-cell lymphoma-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Predictive model for the risk of cytokine release syndrome with glofitamab treatment for diffuse large B-cell lymphoma

Published:2024-07-10 Issue:14 Volume:8 Page:3615-3618
ISSN:2473-9529
Container-title:Blood Advances
language:en
Short-container-title:

Author:

Gritti Giuseppe¹,Belousov Anton²,Relf James³,Dixon Mark³,Tandon Maneesh³,Komanduri Krishna⁴

Affiliation:

1. 1UC Ematologia Ospedale Papa Giovanni XXIII, Bergamo, Italy

2. 2F. Hoffmann-La Roche Ltd, Basel, Switzerland

3. 3Roche Products Ltd, Welwyn Garden City, United Kingdom

4. 4Division of Hematology and Oncology, The University of California San Francisco, San Francisco, CA

Publisher

American Society of Hematology

Link

https://ashpublications.org/bloodadvances/article-pdf/8/14/3615/2235607/blooda_adv-2023-011089-main.pdf

Reference15 articles.

1. Cytokine release syndrome associated with T-cell-based therapies for hematological malignancies: pathophysiology, clinical presentation, and treatment;Cosenza;Int J Mol Sci,2021

2. Cytokine release syndrome and associated neurotoxicity in cancer immunotherapy;Morris;Nat Rev Immunol,2022

3. Immunotherapy of acute lymphoblastic leukemia and lymphoma with T cell-redirected bispecific antibodies;Lussana;J Clin Oncol,2021

4. Characteristics and risk factors of cytokine release syndrome in chimeric antigen receptor T cell treatment;Yan;Front Immunol,2021

5. Consensus recommendations on the management of toxicity associated with CD3xCD20 bispecific antibody therapy;Crombie;Blood,2024

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP